Allurion Technologies ALUR.WS

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.01 (-27.50%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Allurion Technologies (ALUR.WS)
    Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.029

    • Price-Earnings Ratio

      -0.07

    • Total Outstanding Shares

      64.37 Million Shares

    • Total Employees

      24

    • Dividend

      No dividend

    • IPO Date

      August 2, 2023

    • SIC Description

      Surgical & Medical Instruments & Apparatus

    • Primary Exchange

      New York Stock Exchange

    • Type

      Warrant

    • Headquarters

      11 huron dr ste 200, Natick, MA, 01760

    • Homepage

      https://www.allurion.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow, Continuing$-51.05 Million
    Net Cash Flow From Investing Activities$-1.01 Million
    Net Cash Flow From Financing Activities, Continuing$-147,000
    Net Cash Flow From Operating Activities$-49.90 Million
    Net Cash Flow From Operating Activities, Continuing$-49.90 Million
    Net Cash Flow From Financing Activities$-147,000

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Nonoperating Income/Loss$34.45 Million
    Diluted Earnings Per Share$-0.41
    Other Operating Expenses$63.94 Million
    Benefits Costs and Expenses$59.13 Million
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
    Income Tax Expense/Benefit$384,000

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Other Comprehensive Income/Loss$2.89 Million
    Comprehensive Income/Loss Attributable To Parent$-21.87 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss$-21.87 Million

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Other Current Assets$40.26 Million
    Inventory$4.57 Million
    Temporary Equity$979,000
    Other Non-current Assets$2.79 Million
    Accounts Payable$10.39 Million
    Liabilities And Equity$50.70 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ALUR.WS from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.